Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Schering AG presents factor Xa/thrombin inhibitors

June 1, 1998

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

P2T purinoceptor receptor antagonists with platelet antiaggregatory activity

May 28, 1998

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

May 26, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

BLA and MAA filed for recombinant factor VIII product for hemophilia A

May 22, 1998

Fibrinogen receptor antagonists claimed by DuPont Merck

May 22, 1998

U.S. market introduction announced for Plavix

May 22, 1998

DuPont Merck presents new anticoagulants

May 21, 1998

Selective thrombin inhibitors described by Merck scientists

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.